Epstein–Barr virus and multiple sclerosis

SS Soldan, PM Lieberman - Nature Reviews Microbiology, 2023 - nature.com
Epstein–Barr virus (EBV) is a ubiquitous human lymphotropic herpesvirus with a well-
established causal role in several cancers. Recent studies have provided compelling …

B cell depletion therapies in autoimmune disease: advances and mechanistic insights

DSW Lee, OL Rojas, JL Gommerman - Nature reviews Drug discovery, 2021 - nature.com
In the past 15 years, B cells have been rediscovered to be not merely bystanders but rather
active participants in autoimmune aetiology. This has been fuelled in part by the clinical …

Heterogeneity of meningeal B cells reveals a lymphopoietic niche at the CNS borders

S Brioschi, WL Wang, V Peng, M Wang, I Shchukina… - Science, 2021 - science.org
INTRODUCTION The meninges are a three-layer membrane that covers the central nervous
system (CNS): The outermost layer, the dura mater, is attached onto the skull periosteum; …

Treatment of multiple sclerosis: a review

SL Hauser, BAC Cree - The American journal of medicine, 2020 - Elsevier
Multiple sclerosis (MS) is an autoimmune demyelinating and neurodegenerative disease of
the central nervous system, and the leading cause of nontraumatic neurological disability in …

The immune response in multiple sclerosis

S Rodríguez Murúa, MF Farez… - Annual Review of …, 2022 - annualreviews.org
Multiple sclerosis (MS) is a chronic autoimmune, inflammatory, and neurodegenerative
disease that affects the central nervous system (CNS). MS is characterized by immune …

[HTML][HTML] Role of microbiota-derived short-chain fatty acids in nervous system disorders

R Mirzaei, B Bouzari, SR Hosseini-Fard… - Biomedicine & …, 2021 - Elsevier
During the past decade, accumulating evidence from the research highlights the suggested
effects of bacterial communities of the human gut microbiota and their metabolites on health …

Ofatumumab versus teriflunomide in multiple sclerosis

SL Hauser, A Bar-Or, JA Cohen, G Comi… - … England Journal of …, 2020 - Mass Medical Soc
Background Ofatumumab, a subcutaneous anti-CD20 monoclonal antibody, selectively
depletes B cells. Teriflunomide, an oral inhibitor of pyrimidine synthesis, reduces T-cell and …

Bruton tyrosine kinase inhibitors for multiple sclerosis

J Krämer, A Bar-Or, TJ Turner, H Wiendl - Nature Reviews Neurology, 2023 - nature.com
Current therapies for multiple sclerosis (MS) reduce both relapses and relapse-associated
worsening of disability, which is assumed to be mainly associated with transient infiltration of …

Convalescent plasma therapy for B-cell–depleted patients with protracted COVID-19

T Hueso, C Pouderoux, H Péré… - Blood, The Journal …, 2020 - ashpublications.org
Anti-CD20 monoclonal antibodies are widely used for the treatment of hematological
malignancies or autoimmune disease but may be responsible for a secondary humoral …

Inebilizumab for the treatment of neuromyelitis optica spectrum disorder (N-MOmentum): a double-blind, randomised placebo-controlled phase 2/3 trial

BAC Cree, JL Bennett, HJ Kim, BG Weinshenker… - The Lancet, 2019 - thelancet.com
Background No approved therapies exist for neuromyelitis optica spectrum disorder
(NMOSD), a rare, relapsing, autoimmune, inflammatory disease of the CNS that causes …